2023 AUA Annual Meeting
April 28 – May 1
Chicago, IL
Chicago, IL
CHANNA A. AMARASEKERA, MD
|
NELSON E. BENNETT JR., MD
|
DIANA K. BOWEN, MD
|
Robert E. Brannigan, MD
|
William J. Catalona, MD
|
DAVID I-WANG CHU, MD
|
Joshua A. Halpern, MD
|
EMILIE K. JOHNSON, MD
|
STEPHANIE J. KIELB, MD
|
DAVID J. KLUMPP, PHD
|
AMY E. KRAMBECK, MD
|
ziho lee, MD
|
JOSHUA J. MEEKS, MD, PHD
|
ADAM B. MURPHY, MD
|
ASHLEY E. ROSS, MD, PHD
|
ANTHONY j. SCHAEFFER, MD
|
EDWARD M. SCHAEFFER, MD, PHD
|
praveen thumbikat, phd
|
ELIZABETH b. YERKES, MD
|
MP13-09: Comparison of outcomes in patients with and without neurological diseases undergoing holmium laser enucleation of the prostate (HoLEP)
MP13: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology I Authors: Jenny Guo, MD; Mark Assmus, MD; Nicholas Dean, MD; Matthew Lee, MD; Jessica Helon, Mitchell Huang, and Amy E. Krambeck, MD |
Friday, April 28
1:00 to 3:00 pm Location: S401A |
MP13-08: Holmium Laser Enucleation of The Prostate (HoLEP) Outcomes After Minimally Invasive Surgical Therapies (MIST) for BPH
MP13: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology I Authors: Nicholas Dean, MD; Mark Assmus, MD; Matthew Lee, MD; Jenny Guo, MD; and Amy E. Krambeck, MD |
Friday, April 28
1:00 to 3:00 pm Location: S401A |
MP13-13: Wolf 24F vs. Storz 28F Laser Scope for Holmium Laser Enucleation of the Prostate (HoLEP): Interim Analysis of a Prospective RCT
MP13: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology I Authors: Nicholas Dean, MD; Matthew Lee, MD; Mark Assmus, MD; Jenny Guo, MD; Jessica Helon, and Amy E. Krambeck, MD |
Friday, April 28
1:00 to 3:00 pm Location: S401A |
MP16-11: Carbonate Apatite Nephrolithiasis
MP16: Stone Disease: Epidemiology & Evaluation I Authors: Nicholas Dean, MD; Jenny Guo, MD; and Amy E. Krambeck, MD |
Friday, April 28
1:00 to 3:00 pm Location: S405 |
BEST POSTER WINNER: MP13-11: Safety and Efficacy of Concurrent Bladder Botox Injection at the Time of Holmium Laser Enucleation of the Prostate: A Comparative Study
MP13: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology I Authors: Mitchell M. Huang, MD; Nicholas Dean, MD; Mark Assmus, MD; Matthew Lee, MD; Jenny Guo, MD; Jessica Helon; and Amy E. Krambeck, MD |
Friday, April 28
1:00 to 3:00 pm Location: S401A |
MP65-20: Small Molecule-Directed Bladder Tissue Regeneration
MP65: Trauma/Reconstruction/Diversion: Augmentation, Substitution, Diversion Authors: Mitali Kini, MD; Matthew Bury; Natalie Fuller; Larry Wang; Tiffany Sharma; and Arun Sharma, PhD |
Friday, April 28
1:00 to 3:00 pm Location: S505 |
MP17-01: Differential Transcriptomic Indicators of Potential Therapeutic Response to Targeted Therapy for AJCC IIC+ Localized Prostate Cancer with Decipher ≥0.95
MP13: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology I Authors: Eric V. Li, MD; James A. Proudfoot, Alex Hakansson, Xin Zhao, Yang Liu, Adam B. Weiner, Edward Schaeffer, MD, PhD, Elai Davicioni, Ashley E. Ross, MD, PhD |
Friday, April 28
1:00 to 3:00 pm Location: S504 |
MP13-19: Prostate Health Index is associated with Incidental Prostate Cancer Detection at Time of Holmium Laser Enucleation of the Prostate
MP13: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology I Authors: Eric V. Li, MD; Jenny Guo, MD; Nicholas Dean, MD; Mark Assmus, MD; Ruoji Zhou; Ashley E. Ross, MD, PhD; Matthew Lee, MD; and Amy E. Krambeck, MD |
Friday, April 28
1:00 to 3:00 pm Location: S401A |
MP13-20: National Uptake of HoLEP is Increasing in Ambulatory Surgery Settings
MP13: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology I Authors: Neil A. Mistry, MD; Jenny Guo, MD; Matthew Lee, MD; Mark Assmus, MD; and Amy E. Krambeck, MD |
Friday, April 28
1:00 to 3:00 pm Location: S401A |
BEST POSTER WINNER: PD08-03: Long-term tumor necrosis factor-alpha inhibitor use increases the risk of Renal Cell Carcinoma
Session: PD08: Kidney Cancer: Epidemiology & Evaluation/Staging/Surveillance I Authors: Conor Driscoll, MD; Jordan Rich, Dylan Isaacson, Joseph Nicolas, Yu Jiang, Xinlei Mi, Christopher Yang, Victoria Kocsuta, Regine Goh, Niti Patel, Eric Li, Rashid Siddiqui, Travis Meyers, John Witte, Linda Kachuri, Hui Zhang, Molly Beestrum; Edward Schaeffer, MD, PhD; and Shilajit Kundu, MD |
Friday, April 28
1:20 to 1:30 pm Location: S401C |
BEST POSTER WINNER: MP22-01: The association between frailty, low testosterone, and postoperative outcomes among men undergoing transurethral resection of bladder tumor
Session: MP22: Bladder Cancer: Epidemiology & Evaluation I Authors: Daniel R. Greenberg, MD; Jasmin S. Lin; Sai Kaushik S. R. Kumar; Xinlei Mi; Edward Schaeffer, MD, PhD; Joshua J. Meeks, MD, PhD; Robert E. Brannigan, MD; and Joshua A. Halpern, MD |
Friday, April 28
3:30 to 5:30 pm Location: S405 |
MP29-12: Characteristics and Outcomes of Patients with Advanced Prostate Cancer Treated with Relugolix: A Single Center Experience
MP29: Prostate Cancer Advanced Authors: Parth Vipul Shah; Eric Li, MD; Anna Monika Busza; Mohammad Rashid Siddiqui, MD; Jonathan Alexander Aguiar; Sai KSR Kumar; Clayton Neill; Mary Kate Keeter; Hiten Patel, MD; Edward Schaeffer, MD, PhD; and Ashley Ross MD, PhD |
Saturday, April 29
7:00 to 9:00 am Location: S505 |
MP30-11: Distribution of Follicle Stimulating Hormone (FSH) Levels Among Fertile and Subfertile Non-azoospermic Men
MP30: Infertility: Epidemiology & Evaluation I Authors: Solomon Hayon, MD; Sai Kaushik S.R. Kumar; Xinlei Mi; Anthony Kang; Jasmine Lin; Daniel Greenberg; Robert E. Brannigan, MD; and Joshua A. Halpern, MD |
Saturday, April 29
7:00 to 9:00 am Location: S505 |
V06-12: Prophylactic Mesh Strips: An effective way to reduce hernia during radical cystectomy
Session: V06: Bladder & Urothelial Upper Tract Oncology Authors: Noah Frydenlund, MD; Eric Li, MD; Clayton Neill, Gregory Dumanian, MD; and Joshua J. Meeks, MD, PhD |
Saturday, April 29
11:20 to 11:30 am Location: Video Abstract Theater |
MP40-04: Long-term tumor necrosis factor-alpha inhibitor use decreases the risk of Prostate Cancer
Session: MP40: Prostate Cancer: Detection & Screening I Authors: Conor Driscoll, MD; Jordan Rich, Dylan Isaacson, Joseph Nicolas, Yu Jiang, Xinlei Mi, Christopher Yang, Victoria Kocsuta, Regine Goh, Niti Patel, Eric Li, Rashid Siddiqui, Travis Meyers, John Witte, Linda Kachuri, Hui Zhang, Molly Beestrum, Edward Schaeffer, MD, PhD, and Shilajit Kundu, MD |
Saturday, April 29
1:00 to 3:00 pm Location: S405 |
MP40-19: West-African Ancestry Can Aid Prediction of High-Grade Prostate Cancer in Black-Tailored Risk Calculator
MP40: Prostate Cancer: Detection & Screening I Authors: Neil A. Mistry, MD; Zequn Sun, Norma Marshall, Rick Kittles, Edward Schaeffer, MD, PhD, Peter Gann, and Adam B. Murphy, MD |
Saturday, April 29
1:00 to 3:00 pm Location: S405 |
BEST POSTER WINNER: MP44-10: The Value of Dynamic Contrast Enhancement for Risk-Stratification and Prostate Cancer Detection on Multiparametric Prostate MRI
MP44: Prostate Cancer: Detection & Screening II Authors: Eric V. Li, MD; Mohammad R. Siddiqui; Jonathan A. Aguiar; Parth V. Shah; Ashorne K. Mahenthiran; Jasmine S. Lin; Soliman AS Moataz; Mary-Kate Keeter; Clayton Neill; Quan Mai; Sai K. Kumar; Xinlei Mi; Edward Schaeffer, MD, PhD; Ashley E. Ross, MD, PhD; Hiten D. Patel, MD |
Saturday, April 29
3:30 to 5:40 pm Location: S403 |
MP44-11: Detection of subsequent clinically significant prostate cancer following initial decision to forgo biopsy in the multiparametric MRI era
MP44: Prostate Cancer: Detection & Screening II Authors: Eric V. Li, MD; Anna M. Busza, Mohammad R. Siddiqui, Jonathan A. Aguiar, Parth V. Shah, Jasmine S. Lin, Ashorne K. Mahenthiran, Soliman AS Moataz, Mary-Kate Keeter, Clayton Neill, Quan Mai, Sai K. Kumar, Xinlei Mi, Edward Schaeffer, MD, PhD, Ashley E. Ross, MD, PhD, Hiten D. Patel, MD |
Saturday, April 29
3:30 to 5:30 pm Location: S403 |
BEST POSTER WINNER: MP51-09: Association between low testosterone and perioperative outcomes in patients undergoing transurethral prostate surgery
MP51: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology II Authors: Jasmin Lin; Daniel Greenberg, MD; Sai Kaushik S. R. Kumar; Xinlei Mi; Edward Schaeffer, MD, PhD; Robert Brannigan MD; Joshua Halpern, MD |
Sunday, April 30
7:00 to 9:00 am Location: S404C |
The Northwestern Medicine Department of Urology is committed to providing personalized, integrative, and innovative urologic care and conducting leading-edge research for the prevention, diagnosis and treatment of urologic conditions.
In light of this commitment, the Urology program at Northwestern Memorial Hospital is the highest-ranked in Illinois and ranks No. 12 in the country according to U.S. News & World Report, 2022 – 2023. |
About Us Terms of Use Privacy Policy
© 2023 Northwestern Medicine® and Northwestern Memorial HealthCare. Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University |
Connect with us
breakthroughsforphysicians@nm.org International physicians, contact international@nm.org |